Untitled

[fernsweb]

Cloud computing Solutions & Benefits for Pharmaceutical Industry

Historically, pharma has been slow to adopt innovative technologies. Today, however, pharma companies are forced to seek out solutions that help optimize their complex processes and reduce their costs. Cloud computing is a highly attractive solution that offers a multitude of benefits without requiring a massive upfront investment.

The global cloud computing market is expected to reach $623.3 billion by 2023.

The trend is clear, cloud computing is on the rise. But what is cloud computing anyway? Tech companies define the term in different ways. Cloud computing is rather a model instead of a particular technology. Cloud computing has limitless potential as it allows pharmaceutical and life sciences companies of any size to access their IT-based services through the Internet.

Private Clouds

This data-storage environment is restricted to a single company for private use. It can be built within your company’s own data center or located off-site. The primary purpose of these types of clouds is to produce virtualized application, infrastructure, and communications services for internal use.

Public Clouds

The public cloud computing market alone generated over $130 billion in 20171. Third-party providers over the Internet offer these public clouds. These are available to anyone who wants to use or purchase them. Customers typically pay only for what they use, and the usage is measured by CPU cycles, storage, or bandwidth.

Hybrid Clouds

Hybrid clouds merge the benefits of public and private clouds. They enable companies to preserve confidential information in a private cloud, and at the same time, have access to a much wider choice of applications available in public clouds.

Community Clouds

Organizations in the same industry sometimes join together to share their resources and create community clouds. This type of cloud can be hosted internally or by third parties. Regardless of the form, cloud computing provides on-demand access at one or more of the following levels:

At the infrastructure level - infrastructure-as-a-service (IaaS)

At the platform level - platform-as-a-service (PaaS)

At the application level - software-as-a-service (SaaS)

At the business process level - business process-as-a-service (BPaaS)

Benefits of Pharma Cloud Computing

Cloud computing offers a multitude of benefits to pharma companies. Some of the most significant advantages are:

1. Cost Savings

Taking your IT-dependent services into the cloud requires far less up-front investment than traditional IT models. If your company is still ”grounded” by old IT-systems, you have probably seen first-hand how expensive it is to maintain and manage them. Instead of investing large sums in the purchase of equipment and systems, you can realize immediate savings by tapping into the resources of your cloud computing service provider.

2 . Data Protection

Pharmaceutical companies spend a fortune on obtaining and maintaining quality data. The industry has a complex sales process that includes multiple players, such as manufacturers, healthcare providers, patients, and health insurance companies. Each step in the process, from manufacturing to filling a prescription, creates more data. Not only it is expensive to gain access to all this information, but it is also challenging to keep the data in a secure and safe location. Storing your data in the cloud allows you to do precisely that, with 24/7 access to it from anywhere in the world.

3. On-Demand Access

There is no need to request more storage space or additional time on the server. The service is continuously there and responsive to your needs, and available on any device that has a web browser.

To learn more about all of P360’s innovative products, visit P360.com.

[fernsweb]

Pharma Compliance: Essential Strategies for Marketing and Sales Excellence

The pharmaceutical industry is a key player in advancing patient care. Through their development of novel diagnostics and therapeutics, physicians and other medical professionals are able to detect and treat health disorders and diseases more effectively. However, like any industry, pharma is not free from legal and ethical standards that must be adhered to. And in the context of pharma marketing and sales, compliance is of vital importance.

Why? Because compliance helps ensure that patient care remains a top priority, above all else. Not to mention, compliant organizations face fewer liabilities. Non-compliance in pharma marketing and sales efforts can result in serious consequences ranging from regulatory fines and lawsuits to reputational harm. There are even criminal considerations.

In March 2023, the Department of Justice (DOJ) updated its Evaluation of Corporate Compliance Programs (ECCP). This document1 is meant to serve as a guidance document for prosecutors when evaluating corporate compliance programs. Among other updates, the ECCP Guidance now includes a new directive for assessing how companies govern employees' use of personal devices, communication platforms and messaging applications.

It’s a lot to take in, and we feel your pain! So, to help executives cut through the compliance clutter, we’re doing a deep dive into why it plays such a crucial role in pharma’s sales and marketing efforts. We’ll look at what compliance means, discuss the risks involved with non-compliance, and outline a framework for achieving compliance in pharma marketing and sales.

[fernsweb]

Unlocking Clinical Trial Efficiency: Embracing Digital Solutions

Clinical trials can be both costly and time consuming, but there are solutions that can help lower costs and create efficiencies. This article provides insights and tips that are sure to help you overcome some of the obstacles keeping you from optimizing your clinical trials.

If you work for a life sciences company specializing in the development of new drugs and therapeutic biological products, then you are probably aware that costs associated with clinical trials have skyrocketed. In fact, according to a 2018 study published in JAMA Internal Medicine, they have increased by nearly 100 percent over the last 10 years.

Clinical trials alone now cost life science companies, on average, anywhere from $12.2 million to $33.1 million. One of the biggest reasons for the rise in cost has to do with optimizing how the trial is conducted and the resources used to execute it.

The good news is, technologies are available today that can help pharmaceutical developers save significant time and money, while also improving processes and workflows. However, CIOs need to look beyond traditional clinical applications and work to implement digital solutions developed specifically for clinical trials, but that also keep the entire enterprise in mind. The reason for this is simple; traditional technologies are somewhat siloed and do not always stretch across research department boundaries. For organizations focused on agile methodologies, this old way of managing clinical trials makes no sense.

Patient Care: Clinical trials offer hope to patients with limited treatment options. Participation in trials can provide access to cutting-edge therapies that might otherwise be unavailable.

To learn more about all of P360’s innovative products, visit P360.com.

[fernsweb]

4 Ways Pharma Data Analytics Helps Streamline Business Decision-Making

The emergence of big data, technological advancements, and data science approaches have dramatically transformed industries like retail, finance, and travel. The Life Sciences industry is no exception. Companies in the Life Sciences industry have a high-volume of unorganized data sets they aren't aware of that contains hidden actionable insights. The life sciences industry hasn't fully adapted to new technologies but they've gotten off to a convincing start. Still, a huge number of enterprises haven't been able to decode the insights because of lack of expertise in pharma data analytics and inefficient pharma master data management. It's an undeniable fact that by leveraging big data and data analytics, pharmaceutical companies can enhance their business processes, accelerate their product development and achieve set sales objectives.

It'll be explained in this article how companies can take advantage of data analytics to boost their pharma sales in today's market.

Over the years, pharma companies have relied on the traditional ways of managing their pharma sales operations. In the past, many pharmaceutical companies would send their representatives to visit doctors personally. This exhausted the resources of the companies and lacked accuracy and actionable insights. With the traditional way of sales promotion, broad-scale production wasn't possible. Thus, the ROI generated was comparatively lower.

Today, the market is still at a fairly nascent stage and there are significant challenges. Such as poor data integration, lack of investment in talent and technology, and limited stakeholder alignment impacting this industry. However, best practices are emerging to help overcome these challenges and push pharma and life sciences analytics further on the path of rapid growth. According to a report by the McKinsey Global Institute, applying big-data strategies to make better-informed decisions could generate up to $100 billion in value annually across the US health-care system.

The report also suggests that the following can change the face of the pharma industry:

Optimizing innovation.

Improving the efficiency of research and clinical trials.

Building new tools for physicians, consumers, insurers, and regulators.

To learn more about all of P360’s innovative products, visit P360.com.

[fernsweb]

Pharma Marketing Unveiled: Strategies for Success and Compliance in the Digital Age

Pharma marketing, simply put, is the strategies and tactics employed by pharma companies to promote and sell their products. This form of marketing focuses on medications and medical services, targeting healthcare professionals, and sometimes directly to consumers. Unlike general marketing, pharma marketing must navigate stringent regulations and ethical considerations, ensuring the accurate and responsible promotion of medical products.

The Vital Role of Marketing in the Pharma Industry

In the pharma industry, marketing plays a crucial role. Marketing is not just about selling drugs or medical services; it's about educating healthcare providers and patients. Pharma marketing is also about raising awareness about diseases and informing about the latest medical advancements.

Effective marketing strategies can lead to increased awareness, better patient outcomes, and ultimately, business growth. It bridges the gap between medical innovations and the people who need them most.

Preview of the Pharma Marketing Guide

This guide will delve into various aspects of pharmaceutical marketing. We'll explore effective pharma marketing strategies, understanding how these strategies can help pharma companies navigate a competitive and highly regulated market. This guide covers digital and traditional pharma marketing methods, focusing on effectiveness and ethical practices. Stay tuned for insightful discussions and practical tips on elevating your pharmaceutical marketing approach.

What is Pharma Marketing?

Pharma marketing is a specialized branch of marketing focusing on promoting and selling pharma products. Its scope goes beyond mere advertising; it encompasses market research, product development feedback, regulatory compliance, and educating healthcare professionals and consumers.

This marketing strategy is crucial for pharma companies to effectively reach their target audience. Which includes doctors, health workers, and directly to patients in some cases.

How Pharma Marketing Differs from General Marketing

Pharma marketing stands apart from general marketing in several ways. It works in a strict environment where all promotions must follow ethical and legal rules.

Unlike general marketing, which can freely use persuasive tactics, pharmaceutical marketing must prioritize accurate information and patient safety. Moreover, the target audience in pharma marketing is more specialized. Pharmaceutical Marketing often focuses on healthcare professionals who require detailed, scientific data rather than just persuasive sales pitches.

Key Challenges in Pharma Marketing

Pharma marketing faces unique challenges. One of the primary challenges is navigating the complex regulatory environment. Ensuring compliance with laws and ethical standards while still effectively marketing products is a delicate balance. One challenge is the need to always come up with new ways to communicate in the changing healthcare field.

Additionally, there is the challenge of building and maintaining trust with healthcare professionals and the public.

Identifying the Target Audience for Effective Pharma Marketing

A key aspect of pharma marketing is identifying and understanding the target audience. The primary groups targeted are doctors, patients, and pharmacies. Each group requires a different approach.

For doctors, the focus is on providing detailed, scientific data about new drugs or treatments.

Patients, on the other hand, need information that is accessible and easy to understand. This often requires focusing on how a product can improve their health and well-being.

Pharmacies are targeted with information about the benefits and availability of products. This requires helping them to effectively supply and recommend them to patients.

Understanding Regulatory Constraints in Pharma Marketing

Pharma marketing operates under stringent regulatory constraints. These regulations ensure that marketing practices are ethical and that the information provided is accurate and not misleading.

Pharma companies must stay updated with these regulations to avoid legal issues and maintain their reputation. This often involves continuous monitoring and adapting marketing strategies to comply with new guidelines. This ensures that companies validate all promotional materials for compliance.

[fernsweb]

2024 Pharma Marketing Trends: Embracing Digital Transformation and Patient-Centric Approach

The year 2024 marks a pivotal era in the pharmaceutical industry. Underscored by rapidly evolving Pharmaceutical Marketing Trends and a significant push towards Digital Transformation in Pharma. This period of transformation demands agility and adaptability from pharmaceutical companies to stay ahead in the competitive landscape.

As we navigate through 2024, the focus is increasingly shifting toward integrating advanced digital technologies into marketing strategies. This approach helps to keep up with technological advancements. Along with this also helps redefine how pharmaceutical companies connect with their audiences. The adoption of these technologies is essential for companies looking to make a substantial impact in the market.

Moreover, a patient-centric approach has become a cornerstone of effective marketing. No longer just about promoting products, it's about engaging with patients and healthcare providers in meaningful ways. This involves understanding their needs and preferences and tailoring communication strategies accordingly.

In essence, Pharmaceutical Marketing Trends in 2024 revolve around embracing digital innovations and prioritizing patient engagement. These trends are changing marketing strategies and how pharmaceutical companies engage with their target audiences. Companies can stay relevant and influential in a changing industry by recognizing and including these trends.

[fernsweb]

Pharma Marketing Unveiled: Strategies for Success and Compliance in the Digital Age

Pharma marketing, simply put, is the strategies and tactics employed by pharma companies to promote and sell their products. This form of marketing focuses on medications and medical services, targeting healthcare professionals, and sometimes directly to consumers. Unlike general marketing, pharma marketing must navigate stringent regulations and ethical considerations, ensuring the accurate and responsible promotion of medical products.

The Vital Role of Marketing in the Pharma Industry

In the pharma industry, marketing plays a crucial role. Marketing is not just about selling drugs or medical services; it's about educating healthcare providers and patients. Pharma marketing is also about raising awareness about diseases and informing about the latest medical advancements.

Effective marketing strategies can lead to increased awareness, better patient outcomes, and ultimately, business growth. It bridges the gap between medical innovations and the people who need them most.

Preview of the Pharma Marketing Guide

This guide will delve into various aspects of pharmaceutical marketing. We'll explore effective pharma marketing strategies, understanding how these strategies can help pharma companies navigate a competitive and highly regulated market. This guide covers digital and traditional pharma marketing methods, focusing on effectiveness and ethical practices. Stay tuned for insightful discussions and practical tips on elevating your pharmaceutical marketing approach.

What is Pharma Marketing?

Pharma marketing is a specialized branch of marketing focusing on promoting and selling pharma products. Its scope goes beyond mere advertising; it encompasses market research, product development feedback, regulatory compliance, and educating healthcare professionals and consumers.

This marketing strategy is crucial for pharma companies to effectively reach their target audience. Which includes doctors, health workers, and directly to patients in some cases.

How Pharma Marketing Differs from General Marketing

Pharma marketing stands apart from general marketing in several ways. It works in a strict environment where all promotions must follow ethical and legal rules.

Unlike general marketing, which can freely use persuasive tactics, pharmaceutical marketing must prioritize accurate information and patient safety. Moreover, the target audience in pharma marketing is more specialized. Pharmaceutical Marketing often focuses on healthcare professionals who require detailed, scientific data rather than just persuasive sales pitches.

Key Challenges in Pharma Marketing

Pharma marketing faces unique challenges. One of the primary challenges is navigating the complex regulatory environment. Ensuring compliance with laws and ethical standards while still effectively marketing products is a delicate balance. One challenge is the need to always come up with new ways to communicate in the changing healthcare field.

Additionally, there is the challenge of building and maintaining trust with healthcare professionals and the public.

[fernsweb]

Pharma Compliance: Essential Strategies for Marketing and Sales Excellence

The pharmaceutical industry is a key player in advancing patient care. Through their development of novel diagnostics and therapeutics, physicians and other medical professionals are able to detect and treat health disorders and diseases more effectively. However, like any industry, pharma is not free from legal and ethical standards that must be adhered to. And in the context of pharma marketing and sales, compliance is of vital importance.

Why? Because compliance helps ensure that patient care remains a top priority, above all else. Not to mention, compliant organizations face fewer liabilities. Non-compliance in pharma marketing and sales efforts can result in serious consequences ranging from regulatory fines and lawsuits to reputational harm. There are even criminal considerations.

In March 2023, the Department of Justice (DOJ) updated its Evaluation of Corporate Compliance Programs (ECCP). This document1 is meant to serve as a guidance document for prosecutors when evaluating corporate compliance programs. Among other updates, the ECCP Guidance now includes a new directive for assessing how companies govern employees' use of personal devices, communication platforms and messaging applications.

It’s a lot to take in, and we feel your pain! So, to help executives cut through the compliance clutter, we’re doing a deep dive into why it plays such a crucial role in pharma’s sales and marketing efforts. We’ll look at what compliance means, discuss the risks involved with non-compliance, and outline a framework for achieving compliance in pharma marketing and sales.

What Does Complaint in Pharma Marketing Mean?

Being compliant in pharma marketing means adhering to the regulatory guidelines and ethical standards set forth by relevant authorities. It involves conducting marketing and promotional activities in a manner that is transparent, accurate and prioritizes patient safety and care. When it comes to pharmaceutical marketing, there are a lot of rules and regulations that companies must follow. But what exactly does compliance look like in practice?

At its most basic level, compliance in pharma marketing refers to following all of the laws and regulations related to drug promotion and advertising. These laws are in place to protect the public from false or misleading information and ensure that drugs are promoted in a safe and effective manner. Some of the key guidelines that companies must follow include:

Disclosing all known risks and side effects of a drug.

Only promoting a drug for its approved use(s).

Not making false or misleading claims about a product's effectiveness or safety.

Including all necessary warnings and precautions in promotional materials.

And while compliance is critical, it can also be challenging to navigate. Some of the common issues that companies face when it comes to staying compliant include:

Balancing the need to promote products with the need to disclose risks and potential side effects.

Staying up to date on changing laws and regulations across multiple jurisdictions.

Managing the complexity of global marketing campaigns that must abide by different rules in different countries.

Ensuring that all employees, from marketing teams to sales reps, are on the same page when it comes to compliance.

By prioritizing these aspects, pharmaceutical companies can ensure that their pharma marketing and sales activities align with legal requirements, ethical considerations, and patient-centered care, ultimately benefiting both the industry and the individuals who rely on their products.

[fernsweb]

4 Ways Technology Can Optimize Clinical Trial Workflows

In 2003, the cost to fully develop an FDA approved drug was  $803 million1. Now, however, that price has skyrocketed up to 2.6 billion and there have been no signs of this rate slowing down!

Unfortunately, while the price to develop drugs have increased, the rate of clinical trial success has decreased by about 12% in this span.

Therefore, this results in ever-increasing pressure to increase efficiency and reduce costs of clinical trials, which can be a major catch-22.

Site directors and managers are fighting an uphill battle to minimize complexity, ensure compliance, and streamline clinical trial processes.

On the other hand, there’s still a practical, regulatory, and ethical obligation to ensure data accuracy and scientific validity.

Automation and workflow technologies help improve workflows…

…but they also may be challenging to implement. What you need to think is, will this all be worth it? The answer is yes.

After all, the majority of pharma companies don’t have in-house teams of software developers ready to take on the challenge of designing workflows which actually keep costs down and reduce complexity.

There are also stringent privacy and regulatory expectations that can impact pharma trials’ priorities.

Still, if they can be merged with existing systems, automated workflows eliminate repetitive, and manually intensive processes.

This simplifies data gathering and analysis, improves communications and productivity levels, and facilitates accurate tracking and reporting on process steps and completion dates.

[fernsweb]

4 Ways Pharma Data Analytics Helps Streamline Business Decision-Making

The emergence of big data, technological advancements, and data science approaches have dramatically transformed industries like retail, finance, and travel. The Life Sciences industry is no exception. Companies in the Life Sciences industry have a high-volume of unorganized data sets they aren't aware of that contains hidden actionable insights. The life sciences industry hasn't fully adapted to new technologies but they've gotten off to a convincing start. Still, a huge number of enterprises haven't been able to decode the insights because of lack of expertise in pharma data analytics and inefficient pharma master data management. It's an undeniable fact that by leveraging big data and data analytics, pharmaceutical companies can enhance their business processes, accelerate their product development and achieve set sales objectives.

It'll be explained in this article how companies can take advantage of data analytics to boost their pharma sales in today's market.

Over the years, pharma companies have relied on the traditional ways of managing their pharma sales operations. In the past, many pharmaceutical companies would send their representatives to visit doctors personally. This exhausted the resources of the companies and lacked accuracy and actionable insights. With the traditional way of sales promotion, broad-scale production wasn't possible. Thus, the ROI generated was comparatively lower.

Today, the market is still at a fairly nascent stage and there are significant challenges. Such as poor data integration, lack of investment in talent and technology, and limited stakeholder alignment impacting this industry. However, best practices are emerging to help overcome these challenges and push pharma and life sciences analytics further on the path of rapid growth. According to a report by the McKinsey Global Institute, applying big-data strategies to make better-informed decisions could generate up to $100 billion in value annually across the US health-care system.

The report also suggests that the following can change the face of the pharma industry:

Optimizing innovation.

Improving the efficiency of research and clinical trials.

Building new tools for physicians, consumers, insurers, and regulators.

[fernsweb]

Pharma Marketing Unveiled: Strategies for Success and Compliance in the Digital Age

Pharma marketing, simply put, is the strategies and tactics employed by pharma companies to promote and sell their products. This form of marketing focuses on medications and medical services, targeting healthcare professionals, and sometimes directly to consumers. Unlike general marketing, pharma marketing must navigate stringent regulations and ethical considerations, ensuring the accurate and responsible promotion of medical products.

The Vital Role of Marketing in the Pharma Industry

In the pharma industry, marketing plays a crucial role. Marketing is not just about selling drugs or medical services; it's about educating healthcare providers and patients. Pharma marketing is also about raising awareness about diseases and informing about the latest medical advancements.

Effective marketing strategies can lead to increased awareness, better patient outcomes, and ultimately, business growth. It bridges the gap between medical innovations and the people who need them most.

Preview of the Pharma Marketing Guide

This guide will delve into various aspects of pharmaceutical marketing. We'll explore effective pharma marketing strategies, understanding how these strategies can help pharma companies navigate a competitive and highly regulated market. This guide covers digital and traditional pharma marketing methods, focusing on effectiveness and ethical practices. Stay tuned for insightful discussions and practical tips on elevating your pharmaceutical marketing approach.

What is Pharma Marketing?

Pharma marketing is a specialized branch of marketing focusing on promoting and selling pharma products. Its scope goes beyond mere advertising; it encompasses market research, product development feedback, regulatory compliance, and educating healthcare professionals and consumers.

This marketing strategy is crucial for pharma companies to effectively reach their target audience. Which includes doctors, health workers, and directly to patients in some cases.

How Pharma Marketing Differs from General Marketing

Pharma marketing stands apart from general marketing in several ways. It works in a strict environment where all promotions must follow ethical and legal rules.

Unlike general marketing, which can freely use persuasive tactics, pharmaceutical marketing must prioritize accurate information and patient safety. Moreover, the target audience in pharma marketing is more specialized. Pharmaceutical Marketing often focuses on healthcare professionals who require detailed, scientific data rather than just persuasive sales pitches.

Key Challenges in Pharma Marketing

Pharma marketing faces unique challenges. One of the primary challenges is navigating the complex regulatory environment. Ensuring compliance with laws and ethical standards while still effectively marketing products is a delicate balance. One challenge is the need to always come up with new ways to communicate in the changing healthcare field.

Additionally, there is the challenge of building and maintaining trust with healthcare professionals and the public.

[fernsweb]

Healthcare Providers' Expectations from Pharma Sales Reps

It’s happened to all healthcare providers (HCPs): we receive a contact request from a pharmaceutical sales representative and immediately roll our eyes upward. Next, we start plotting how to avoid responding to the request from the rep; we just don’t have time to listen to more drug sales pitches.

That’s why instead of focusing 100% on sales, pharmaceutical reps should consider ways they can improve the day-to-day of an HCP. If reps prioritized value-added services during their visits, HCPs would look forward to meetings rather than dread them. Of course, pharmaceutical companies still need to sell their products; that’s how they stay in business. But if reps emphasized how they can help improve patient care during their sales pitches, HCPs would feel differently about meeting with them.

HCP medical offices are the primary resource patients have for qualified professional information about drugs. Therefore, it stands to reason that HCPs want to keep current about drug information and provide patients with the most cost-friendly and user-friendly prescriptions. Pharma reps can be a prime source of information and assistance to HCPs in meeting these objectives.

The American Medical Association (AMA) created the Steps Forward™ program to provide “a collection of engaging and interactive educational toolkits that are practical, actionable “how-to” guides to transform and improve your [HCP] practice.” Because of the importance of pharmaceutical-related issues with clinical practices, the Steps Forward program includes a section on collaboration with pharmacists. Although written specifically pertaining to pharmacists and pharmacy technicians, this section of the AMA’s Steps Forward program can also be viewed within the framework of benefits to HCPs when working with pharma reps. Using the Steps Forward program as a model, I’d suggest that pharma reps can improve their reach by being aware of and addressing the following with HCPs:

Identifying the specific beneficial role pharma reps can play in HCPs’ practices.

Learning from HCPs what they view as characteristics that make pharma reps good matches for HCPs’ individual practices.

Determining how to integrate pharma reps into HCP practice workflows the best way possible.

Assisting HCPs with evaluating and monitoring the (hopefully positive) impact pharma reps have on their clinical practices. This can include clinical patient outcomes, patient prescription cost benefits and other areas. While a particular clinical practice may be smaller and not have time to do formal impact studies, even informal impact monitoring may be informative and eye-opening for HCPs.

There are several different types of information and services pharmaceutical companies can provide that HCPs would find helpful. These include the following, and there are likely others, pertaining to the therapeutics the company manufactures and/or sells:

Identifying lower-cost prescription alternatives to current drug regimens HCPs use.

Providing medication educational material for HCPs and their patients.

Providing patient medication adherence information and tips HCPs can distribute to patients.

Providing the medical care team with clinical drug information.

Assisting patients with information about cost management programs, including drug coupons or prescription discount programs (such as general drug discount cards).

Providing HCPs with information about new medications and new classes of medications.

Providing information about new generics (this applies to generics manufacturers and sellers).

Providing information about new disease treatments and medication step-management guidelines.

Providing information about drug safety.

Assisting HCPs with formulary restrictions and other utilization controls.

Providing drug clinical efficacy information.

Pharma reps can emphasize the following benefits to clinical practices when interacting with HCPs:

Drug cost containment for patients. HCPs will appreciate this since it’s likely to result in increased patient satisfaction. Pharma reps can assist with the above-noted cost assistance measures, and provide drug coupons that are not readily otherwise available to patients.

Overall HCP practice drug cost-containment by using cost-efficient medications.

Improved clinical outcomes through optimal medication choices.

Improved patient medication adherence by prescribing more patient schedule-friendly medications.

Improve clinical outcomes by keeping HCPs informed about:

Current clinical therapeutics

Current clinical guidelines

New drug alternatives

[fernsweb]

Forbes: P360 is Changing How Life Sciences Companies Communicate

At P360 our mission is to help healthcare professionals and life sciences companies form deeper, more symbiotic relationships. The key to this is better communication. That’s why we are putting so much of our effort into developing innovative technologies that help life sciences companies better engage with their physician customers. Forbes has even recognized our efforts in this recent article1 on the topic.

When it comes to our solutions, P360 takes a holistic approach to solving some of the life science industry’s most complex problems. By leveraging technologies that most healthcare professionals already use in their daily lives we are able to provide convenient access while delivering a user experience that is both intuitive and frictionless. For example, our Swittons IoT-powered smart devices help sales reps engage with physicians in a less abrasive, more physician-driven manner. Not only do our Swittons smart devices solve several issues for sales reps, they have also revolutionized the engagement experience for physicians.

Actions like ordering samples or requesting drug consultations have never been easier and more intuitive. Previously, these requests were somewhat complicated because multiple devices and systems were involved – some digital and some paper. With Swittons, all that a prescriber needs to do is push a button and the rest is taken care of automatically.

However, Swittons isn’t the only product we have in our portfolio to help move the industry forward. Another product we recently launched is the BirdzAI ZING Communication Module, also known as simply ZING. We launched ZING to bring a new channel of engagement to life sciences companies that enables them to communicate with healthcare professionals and patients in an easy, compliant manner. ZING does this by: including asset and message templates that can be preapproved by compliance; providing detailed records and traceability of conversation, and integration with existing commercial infrastructure.

[fernsweb]

Pharma Compliance

Why Compliance Standards Matter in Pharma Marketing

The pharmaceutical industry is highly regulated, and this is important for several reasons. First, the industry involves people's health and well-being. And second, healthcare is a major expense for most people. For these reasons, governments and industry bodies have put strict regulations and guidelines in place to ensure that drugs are marketed and sold ethically and responsibly. Let's delve into the key reasons why compliance is crucial in Pharma Marketing:

Patient Safety: Compliance regulations in pharma marketing and sales are designed to prioritize patient safety. By adhering to approved indications, providing accurate and balanced information, and promptly reporting adverse events, compliance helps ensure that patients receive medications that are appropriate for their specific conditions. It prevents off-label promotion, misleading claims and potential risks associated with inaccurate or incomplete information.

Regulatory Adherence: Pharmaceutical companies operate within a complex web of regulations and guidelines enforced by regulatory bodies such as the FDA, EMA and other authorities. Compliance ensures that companies meet the legal requirements and standards set forth by these regulatory agencies. Failure to comply can result in significant penalties, fines, legal repercussions and reputational damage for the organization.

Ethical Standards: Compliance in pharma marketing and sales upholds ethical standards in the industry. It ensures that promotional activities are conducted with integrity, transparency and fairness. By providing truthful and balanced information, avoiding conflicts of interest and disclosing financial relationships, compliance fosters trust among healthcare professionals, patients and the public. It contributes to maintaining the reputation and credibility of pharmaceutical companies.

Protection against Misleading Practices: Compliance regulations safeguard against misleading marketing practices. They prevent the dissemination of false or exaggerated claims about pharmaceutical products, ensuring that patients and healthcare professionals receive accurate information to make informed decisions. Compliance guidelines also govern advertising content, ensuring that it is fair, balanced and does not unduly influence patients' choices.

Preventing Off-Label Promotion: Compliance guidelines in pharma marketing strictly prohibit off-label promotion, which refers to marketing a medication for uses not approved by regulatory agencies. This is important because off-label use can pose potential risks, as the medication may not have undergone rigorous testing or be supported by sufficient evidence for the specific use. Compliance prevents companies from making misleading claims or encouraging off-label use, protecting patients from potential harm.

Reputation and Trust: Compliance in pharma marketing and sales is vital for building and maintaining a positive reputation in the industry. By adhering to ethical standards and regulatory requirements, companies demonstrate their commitment to patient welfare and responsible business practices. This fosters trust among healthcare professionals, patients, regulatory authorities and other stakeholders, enhancing the company's standing and long-term success.

Additionally, non-compliance can be costly. That’s why it’s important to understand the risks associated with non-compliance in pharma sales and marketing. Below are a few of the risks executives need to consider.

[fernsweb]

ZING Powers HCP Engagement

Against the backdrop of changing policies, mounting regulation and skyrocketing costs, pharmaceutical companies are investing heavily in their organization’s digital transformation. Everything from how R&D is conducted to how brands connect with HCPs and patients is being reinvented. And for pharmaceutical sales operations, improving prescriber engagement is the top priority. But unfortunately, many of the current solutions ignore one very important thing: what prescribers want when it comes to the pharma-physician relationship.

During a recent P360 masterclass1, double board-certified physician Dr. Mandira Mehra confirmed that, from a doctor’s standpoint, communication with pharma reps has become inefficient. Although an integral part of a physician’s work, she noted that the process of accessing or contacting reps can be very frustrating.

“Physicians want engagement at their own pace, at their own time, and they want to initiate it,” said Dr. Mehra. “I still have a stack of business cards with the information of 20-30 different pharmaceutical and medical device reps. I cannot think of any other industry that would do that—if I order food or call a cab, everything is streamlined and really done through the phone.”

Dr. Mehra isn’t alone when it comes to wanting a more convenient, digital-first pharma-to-physician relationship. Physicians now prefer digital communication to all other modes of engagement. In a survey conducted by Accenture, 87% of providers2 reported a preference for virtual, or a mix of virtual and in-person, meetings with pharmaceutical reps. In addition, the online HCP community Sermo found that 67% of its users3 felt pharma companies could improve communications with physicians and provide better support for prescribing decisions with on-demand access to reps.

That’s why we developed the ZING Engagement Suite. ZING is a comprehensive unified communications as a service (UCaaS) solution that enables compliant HCP engagement by enhancing existing communication channels with tons of features, including text messaging, two-way voice and video calling, onscreen collaboration and form sharing, inbound communications with QR code scanning, artificial intelligence (AI) assistance, signature capture, easy access integrations and more.

How intelligent bots and QR codes can improve HCP engagement

Strengthened with several enterprise-grade features, ZING is a robust unified communications as a service (UCaaS) platform that enables pharmaceutical sales teams to engage with HCPs via multiple modalities without barriers. In addition to all the features listed above, ZING enables sales teams to deploy intelligent bots and use QR codes to make communication easier. Here’s how those features help improve HCP engagement.

Intelligent bots: ZING can power pharma reps with automated responses to inbound requests (e.g., co-pay card requests). And when needed, reps can seamlessly transition back to themselves. The bots can even be personalized for each territory, rep and brand.

Intelligent bots improve HCP engagement by:

Removing compliance issues

Giving HCPs instant access to what they want, when they want it

Eliminates missed follow-ups when out of the office or out of reach

Removing white space issues

Simplifying access to reps and important drug information

QR codes: ZING makes it easy for pharma reps to provide HCPs with QR codes, which is a type of barcode that can be read by a smartphone. Like links, QR codes enable instant text, call or video communication. The QR codes can even be personalized for each brand. And they can be programmed to connect directly to the appropriate rep.

QR codes improve HCP engagement by:

Removing the need for business cards, which are easily lost

Making it easy to keep contact information up to date, even with turnover, etc.

Making it easy for HCPs to remember what drug goes with which rep

Streamlining communications

Eliminating the need for emails, phone calls and in-person visits

Compliance enabled HCP communication

83% of the pharmaceutical executives we surveyed said compliance is their top priority. The reason being is that compliance-related violations cost companies millions of dollars each year. But with the ZING, avoiding compliance issues is a breeze. All the messages, digital assets and replies sales teams send to HCPs can be preapproved by compliance and preloaded into the system. That way, nothing gets out that isn’t already approved.

In addition, ZING’s intuitive user portal, which can be branded and completely customized, offers administrators a simple way to track individual messages, link clicks, digital asset views and more. And all of ZING’s data can be stored for up to 10 years and pulled into a report for legal upon request. The data from the system also integrates back to sales profiles in existing CRM systems.

ZING makes HCP engagement easy

With the ZING, pharma teams can exchange compliance-enabled two-way unified messaging with healthcare professionals without barriers. There are no apps for end-users to download and there are no subscriptions for them to deal with. To HCPs, ZING offers a seamless, hassle-free experience that’s seen as nothing different than their normal method for receiving texts. To do this, ZING uses native text messaging on an HCPs iOS or Android device with pre-built integrations with major CRMs.

ZING also makes it easy for pharma IT teams in terms of data management and integrity for things like territory alignments, roster changes and other specific data integration needs. Compliance can track every communication, end-to-end. And managers can measure activity and results with ZING’s powerful dashboards.

To learn more about all of P360’s innovative products, visit P360.com.

[fernsweb]

Drive Rx With Pharma Cloud Computing

Pharma companies have begun to realize that to stay competitive, they can no longer afford to conduct their business with traditional methods. A one-size-fits-all sales strategy no longer works!

Pricing pressures brought on by a plethora of healthcare reforms, intensifying competition, and a hostile regulatory environment have all contributed to the industry’s shrinking revenues.

To further complicate the situation, access to physicians has been progressively getting worse, making it far more complicated for pharma sales teams to get in front of HCPs and educate them in the process.

Cloud-Based Technology Is Changing The World Of Pharma Sales

Cloud computing has been around approximately 20 years, and several industries have embraced it since the beginning. So, what exactly is cloud computing?

Cloud computing is a technology where the software is not installed on individual desktops; instead, it’s hosted on a web-based server, offering on-demand software availability.

The pharma and biotech industries were among the first to adopt cloud-based capabilities to equip their sales force with digital technology.

Data shows that about  81 percent of biotech and pharma companies  have adopted cloud mail and core applications. Another 60 percent have brought on sales and marketing, human resources, and other applications.

From a pharma company’s perspective, the biggest benefits of using cloud computing are:

Sales reps can increase their effectiveness by accessing shared data stored remotely.

Working in the cloud allows your sales team to make use of mobile e-detailing tools.

Research shows that going cloud-based is a sound business investment that’s likely to yield a considerable ROI.

According to a Dell report, companies that invest in cloud technology, digital technology, security solutions, and data analytics solutions have their revenue increased by up to 53 percent faster5 than competitors uninterested in these various forms of technology.

Besides the impressive ROI, cloud-based systems are particularly attractive to pharma companies as they don’t require a massive upfront cost with their pay-as-you-go set-up, and reasonably low equipment, installation, and maintenance costs.

5 Ways Pharma Companies Can Benefit From Cloud Computing Solutions

By creating an integrated digital strategy and by making data safe, sound, and widely accessible, you will help empower your sales team to make better business decisions.

When done correctly, going cloud-based enables you to achieve precisely that. 

The performance of pharma sales teams relies on a CRM system to manage its daily operations. It’s crucial to provide your sales team with an easy to learn and flexible CRM platform that gives access to all critical market data.

Cloud-based systems allow you to provide your sales team with access to smart reports and dashboards that offer actionable insights, call activity, and sales data that your team needs to make informed decisions in the field.

Old data frustrates pharma sales reps and relying on them leads to missed opportunities. Real-time reporting that combines information from various sources will ultimately result in cost reduction and an overall more productive sales force.

Having access to a CRM platform both online and offline carries major advantages. An offline platform enables pharma sales reps during their sales calls to capture real-time information and interactions.

Receiving ongoing data input is vital to accurate analytics. A cloud-based CRM solution can drastically simplify customer relationships and business processes, as long as it offers a user-friendly interface and ease of CRM management.

In today’s rapidly developing high-tech environment, the ability to provide feedback from within the CRM application is a must-have.

Choose a platform that has a modern feel and user-friendly design to help engage sales reps and entice them to use the functionalities to its full capacity.

3. Integrated Application

Do you have a system in place that allows for the integration of all your sales and marketing campaigns in a single application? Once again, a cloud-based CRM serves as a robust sales and marketing tool.

By doing so, it acts as a hub, driving follow-up communications with customers based on specific needs. Focused segmentation is essential for achieving pharma sales growth.

Cloud-based platforms make information accessible to anyone, from anywhere at any time. This is huge, as data is gathered and analyzed from a single location, combining the efforts of the whole organization as a team.

4. Engaged Sales Teams

Cloud-based or not, acceptance by your sales team is vital for success. If your pharma sales reps aren’t willing to start incorporating the new tools into their daily routine, even the best technology will be worthless.

So why not ask your field reps about their level of satisfaction with the existing CRM features and functionalities? Why not get them involved in the early stages and get them excited about the upcoming upgrade?

Just imagine how much more smooth the roll-out will be with most of your sales force already on board.

Explain the benefits of your new system to your representative and stress how the advanced features will make their life easier.

The goal is for your sales reps to be able to manage their daily activities without ever having to connect to the internet and be able to perform tasks effortlessly through a simplified workflow logic.

A smart sales force effectiveness system is an excellent tool for increasing the level of your sales team skills.

5. Stellar Execution

Investing in cloud computing benefits pharma companies in multiple ways including:

Increased sales productivity.

Additional in-depth insight into the performance of sales teams, which in turn can help sales management intervene when necessary and improve sales team performance much faster.

Enhances the ability to segment customers more accurately, resulting in tailored communication and more effective message delivery.

To learn more about all of P360’s innovative products, visit P360.com.

[fernsweb]

Cloud Technology Transforms Life Science Companies

Cloud solutions enable life science companies to streamline their operations, eliminating the need for extensive on-premises infrastructure and associated maintenance costs. The scalability of cloud services allows for rapid adjustments to accommodate changing demands, ultimately enhancing responsiveness and efficiency. Moreover, cloud-based collaboration tools facilitate seamless communication among teams and partners, accelerating innovation and decision-making processes. This transformation not only empowers life science companies to stay competitive but also positions them to better serve patients and stakeholders while optimizing their financial resources. Cloud integration is indeed a pivotal step towards a brighter, more agile future for the life science industry.

Cloud-Powered Innovation: A Catalyst for Advancing New-Product Development in Life Science Companies

In the realm of life science companies, the cloud has emerged as a formidable force propelling innovation and new product development. The continuous influx of data from diverse sources, coupled with cutting-edge technologies, has created fertile ground for transformative advancements. Cloud technology serves as the cornerstone, facilitating the seamless integration and analysis of this data, thereby providing a constant boost to the development of novel medicines and services.

Life science companies harness the cloud's vast computing power and storage capabilities to accelerate research, conduct complex simulations, and extract valuable insights from the wealth of data at their disposal. The combination of data and innovation that is powered by the cloud drastically accelerates research and development, while also increasing the accuracy and effectiveness of new products or services. As life science companies continue to leverage the cloud's potential, they are poised to revolutionize healthcare and improve the well-being of individuals worldwide.

Fostering Collaboration and Cost Control: Cloud-Powered Solutions for Life Science Companies

In the realm of life science companies, cloud technology is playing a pivotal role in promoting cross-enterprise collaboration and effective cost management. By embracing the cloud, these organizations are unlocking opportunities to streamline their operations and outsource specific R&D tasks, which has a profound impact on controlling costs and driving innovation.

Cloud technology makes it easy to share information and data among all, from internal teams to external partners and even third-party service providers. Communication is made easy thanks to the convenience of cloud solutions!

This connectivity allows for greater collaboration across the board - providing a far more efficient way of working together. This newfound connectivity enables life science companies to tap into a global pool of talent and resources, effectively outsourcing specific R&D functions. This approach not only reduces overhead costs but also accelerates the pace of research and development of companies adopting cloud technology.

Cloud technology is the catalyst that propels life science companies towards effortless cross-enterprise collaboration; by seamlessly connecting them with experts and service providers across geographical boundaries, it empowers them to embrace a more streamlined, cost-effective, and innovation-centric approach to accomplishing their objectives.

Revolutionizing Research: Cloud-Powered Virtual Laboratories in Life Science Companies

Cloud technology has ushered in a new era of experimentation and innovation for life science companies. Among the most groundbreaking cloud solutions is the virtual laboratory platform, a game-changer that is rapidly transforming the industry. Accessible through various devices via secure internet connections, these virtual laboratories are staffed by experts from contract research companies, providing invaluable support to scientists.

The integration of virtual staff brings efficiency and flexibility to experiments, with real-time feedback and assistance. What's more, cloud-based platforms make it possible to bring together data from clinical trials conducted by partners such as contract research organizations, teaching hospitals, and academic institutions - a huge leap forward in collaboration! This data consolidation enhances research outcomes and accelerates the development of innovative technologies.

Patient services platforms, powered by the cloud, have become an indispensable tool for life science companies, propelling them toward groundbreaking discoveries and more effective patient-centered solutions.